{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:34:34Z","timestamp":1793208874978,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We evaluated hypofractionated proton beam therapy (PBT) feasibility for unresectable hepatoblastoma (HBL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observations:<\/jats:title>\n                    <jats:p>Six patients with residual\/relapsed localized HBL received PBT (50 to 60\u00a0Gy (RBE) in 10 fractions) between April 2019 and September 2024, with follow-up through September 2025. After 55-month follow-up, 5 patients remained alive without disease. One marginal recurrence was successfully salvaged by re-irradiation, and another bridged to hepatectomy (10% viable tumor). Toxicities were minimal, with one grade 2 duodenitis. One patient died of treatment-unrelated myelodysplastic syndrome while remaining HBL-free.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Hypofractionated PBT is a feasible, well-tolerated salvage option for refractory HBL, providing encouraging local control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003291","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:00:20Z","timestamp":1790787620000},"page":"388-393","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hypofractionated Proton Beam Therapy for Localized Residual or Recurrent Unresectable Hepatoblastoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Yu-Chen","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Chang Gung Memorial Hospital, Keelung, Taiwan"},{"name":"Department of Radiation Oncology and Proton Therapy Center, L"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang-Her","family":"Jaing","sequence":"additional","affiliation":[{"name":"Pediatrics, Division of Pediatric Hematology-Oncology, Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-3130","authenticated-orcid":false,"given":"Ting-Chi","family":"Yeh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, MacKay Children\u2019s Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Proton Therapy Center, L"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Heng","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Proton Therapy Center, L"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0087-0340","authenticated-orcid":false,"given":"Chen-Kan","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Proton Therapy Center, L"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"e29763","DOI":"10.1002\/pbc.29763","article-title":"Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States","volume":"69","author":"Kahla","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20261028","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pedneo.2021.03.018","article-title":"A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: a single institution experience","volume":"62","author":"Hou","year":"2021","journal-title":"Pediatr Neonatol"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00383-002-0906-0","article-title":"Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma","volume":"19","author":"Matsunaga","year":"2003","journal-title":"Pediatr Surg Int"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.23301","article-title":"Initial liver transplantation for unresectable hepatoblastoma after chemotherapy","volume":"57","author":"Hery","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jpedsurg.2015.10.053","article-title":"Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy","volume":"51","author":"Shi","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.ajt.2026.03.025","article-title":"Achieving zero waitlist mortality for children on the pediatric liver transplant waitlist","volume":"26","author":"King","year":"2026","journal-title":"Am J Transplant"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/jpm11111173","article-title":"Circuitous path to live donor liver transplantation from the coordinator\u2019s perspective","volume":"11","author":"Lin","year":"2021","journal-title":"J Pers Med"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"djx031","DOI":"10.1093\/jnci\/djx031","article-title":"Phase II study of proton-based stereotactic body radiation therapy for liver metastases: importance of tumor genotype","volume":"109","author":"Hong","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/0284186X.2012.760849","article-title":"Proton beam therapy for unresectable hepatoblastoma in children: survival in one case","volume":"52","author":"Oshiro","year":"2013","journal-title":"Acta Oncol"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00431-025-06471-4","article-title":"The changes in imaging following proton beam therapy for pediatric hepatoblastoma","volume":"184","author":"Lin","year":"2025","journal-title":"Eur J Pediatr"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0360-3016(92)90007-5","article-title":"Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children?","volume":"23","author":"Habrand","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","article-title":"Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)","volume":"49","author":"Semeraro","year":"2013","journal-title":"Eur J Cancer"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MPH.0000000000002824","article-title":"Second malignant neoplasms following treatment for hepatoblastoma: an international report and review of the literature","volume":"46","author":"Trobaugh-Lotrario","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"225009","DOI":"10.1088\/1361-6560\/aae8a5","article-title":"LET-weighted doses effectively reduce biological variability in proton radiotherapy planning","volume":"63","author":"McMahon","year":"2018","journal-title":"Phys Med Biol"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.blre.2016.11.002","article-title":"Therapy-related myelodysplastic syndromes, or are they?","volume":"31","author":"Abou Zahr","year":"2017","journal-title":"Blood Rev"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers18050879","article-title":"Pediatric hepatoblastoma: from developmental molecular mechanisms to innovative therapeutic strategies","volume":"18","author":"Scurtu","year":"2026","journal-title":"Cancers (Basel)"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijrobp.2023.06.002","article-title":"Liver late effects in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review","volume":"119","author":"Hall","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:00:17Z","timestamp":1793206817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003291","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"2026-03-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}